{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:29:29Z","timestamp":1759400969622,"version":"build-2065373602"},"reference-count":84,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.nrl.2019.10.010","type":"journal-article","created":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T07:42:53Z","timestamp":1579333373000},"page":"794-805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Meningitis neopl\u00e1sica en tumores s\u00f3lidos: revisi\u00f3n actualizada de diagn\u00f3stico, pron\u00f3stico, manejo terap\u00e9utico y direcciones futuras"],"prefix":"10.1016","volume":"37","author":[{"given":"E.","family":"Garc\u00eda Molina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Penas-Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2019.10.010_bib0430","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ctrv.2015.12.004","article-title":"Therapy of leptomeningeal metastasis in solid tumors","volume":"43","author":"Mack","year":"2016","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.nrl.2019.10.010_bib0435","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S1470-2045(10)70034-6","article-title":"Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours","volume":"11","author":"Beauchesne","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0440","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1634\/theoncologist.2008-0138","article-title":"Neoplastic meningitis","volume":"13","author":"Chamberlain","year":"2008","journal-title":"Oncologist."},{"key":"10.1016\/j.nrl.2019.10.010_bib0445","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/B978-0-444-53502-3.00022-7","article-title":"Neoplastic meningitis","volume":"105","author":"Chamberlain","year":"2012","journal-title":"Hand Clin Neurol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0450","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/ijc.30147","article-title":"Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy","volume":"139","author":"Smalley","year":"2016","journal-title":"Int J Cancer."},{"key":"10.1016\/j.nrl.2019.10.010_bib0455","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","article-title":"Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90patients","volume":"49","author":"Wasserstrom","year":"1982","journal-title":"Cancer."},{"key":"10.1016\/j.nrl.2019.10.010_bib0460","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.3748\/wjg.15.5086","article-title":"Gastric leptomeningeal carcinomatosis: Multi-center retrospective analysis of 54 cases","volume":"15","author":"Oh","year":"2009","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0465","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1007\/s12032-011-0076-9","article-title":"Leptomeningeal carcinomatosis from ovarian cancer","volume":"29","author":"Miller","year":"2012","journal-title":"Med Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0470","doi-asserted-by":"crossref","first-page":"6e","DOI":"10.1177\/030089161309900124","article-title":"Leptomeningeal metastasis from prostate cancer","volume":"99","author":"Cante","year":"2013","journal-title":"Tumori."},{"key":"10.1016\/j.nrl.2019.10.010_bib0475","first-page":"e183","article-title":"Leptomeningeal carcinomatosis in colorectal cancer: The Mayo Clinic experience","volume":"17","author":"Taylor","year":"2018","journal-title":"Clin Colorectal Cancer."},{"key":"10.1016\/j.nrl.2019.10.010_bib0480","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archneur.1996.00550070064013","article-title":"Leptomeningeal carcinomatosis: Presenting features and prognostic factors","volume":"53","author":"Balm","year":"1996","journal-title":"Arch Neurol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0485","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.nrl.2010.07.020","article-title":"Neoplastic meningitis. Review of a clinical series","volume":"26","author":"Jim\u00e9nez Mateos","year":"2011","journal-title":"Neurologia."},{"key":"10.1016\/j.nrl.2019.10.010_bib0490","doi-asserted-by":"crossref","first-page":"73312","DOI":"10.18632\/oncotarget.20272","article-title":"Leptomeningeal disease: Current diagnostic and therapeutic strategies","volume":"8","author":"Nayar","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.nrl.2019.10.010_bib0495","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1941874416648194","article-title":"Electrographic correlates of plateau waves in patients with leptomeningeal Metastases","volume":"6","author":"Gold","year":"2016","journal-title":"Neurohospitalist."},{"key":"10.1016\/j.nrl.2019.10.010_bib0500","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/WCO.0000000000000393","article-title":"Leptomeningeal metastases of solid cancer","volume":"29","author":"Le Rhun","year":"2016","journal-title":"Curr Opin Neurol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0505","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.40.3_Part_1.435","article-title":"Leptomeningeal metastasis: A comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain","volume":"40","author":"Chamberlain","year":"1990","journal-title":"Neurology."},{"issue":"4 Suppl 2","key":"10.1016\/j.nrl.2019.10.010_bib0510","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.seminoncol.2009.05.005","article-title":"Diagnostic tools for neoplastic meningitis: Detecting disease, identifying patient risk and determining benefit of treatmet","volume":"36","author":"Charmberlain","year":"2009","journal-title":"Semin Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0515","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/1941874415591702","article-title":"Nonenhancing leptomeningeal metastases: Imaging characteristics and potential causative factors","volume":"6","author":"Hatzoglou","year":"2016","journal-title":"Neurohospitalist."},{"key":"10.1016\/j.nrl.2019.10.010_bib0520","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jocn.2014.10.022","article-title":"Treatment of leptomeningeal carcinomatosis: Curret changelles and future opportunities","volume":"22","author":"Kak","year":"2015","journal-title":"J Clin Neurosci."},{"key":"10.1016\/j.nrl.2019.10.010_bib0525","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11060-010-0524-y","article-title":"Meningeal carcinomatosis in breast cancer: Prognostic factors and outcome","volume":"104","author":"De Azevedo","year":"2011","journal-title":"J Neurooncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0530","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1315::AID-CNCR14>3.0.CO;2-4","article-title":"Meningeal carcinomatosis in patients with breast carcinoma Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen","volume":"77","author":"Fizazi","year":"1996","journal-title":"Cancer."},{"key":"10.1016\/j.nrl.2019.10.010_bib0535","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/0-387-24199-X_2","article-title":"Leptomeningeal neoplasia: Epidemiology, clinical presentation, CSF analysis and diagnostic imaging","volume":"125","author":"Enting","year":"2005","journal-title":"Cancer Treat Res."},{"key":"10.1016\/j.nrl.2019.10.010_bib0540","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/neuonc\/nor172","article-title":"Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis","volume":"14","author":"Subir\u00e1","year":"2012","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0545","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood-2004-05-1982","article-title":"High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: The role of flow cytometry versus cytology","volume":"105","author":"Hegde","year":"2005","journal-title":"Blood."},{"key":"10.1016\/j.nrl.2019.10.010_bib0550","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1097-0339(200012)23:6<369::AID-DC1>3.0.CO;2-3","article-title":"Diagnosing lymphoproliferative disorders involving the cerebro-spinal fluid: Increased sensitivity using flow cytometric analysis","volume":"23","author":"French","year":"2000","journal-title":"Diagn Cytopathol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0555","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1212\/01.wnl.0000261909.28915.83","article-title":"CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies","volume":"68","author":"Bromberg","year":"2008","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2019.10.010_bib0560","doi-asserted-by":"crossref","first-page":"752","DOI":"10.18632\/oncotarget.336","article-title":"Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases","volume":"2","author":"Patel","year":"2011","journal-title":"Oncotarget."},{"key":"10.1016\/j.nrl.2019.10.010_bib0565","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10549-015-3610-1","article-title":"Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer","volume":"154","author":"Lee","year":"2015","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.nrl.2019.10.010_bib0570","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jnen\/nly046","article-title":"Evaluating circulating tumor DNA from the cerebrospinal fluid of patients with melanoma and leptomeningeal disease","volume":"77","author":"Ballester","year":"2018","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0575","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1200\/JCO.2016.66.6487","article-title":"Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid","volume":"34","author":"Pentsova","year":"2016","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0580","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1227\/01.NEU.0000043929.31608.62","article-title":"Combined-modality treatment of leptomeningeal gliomatosis","volume":"52","author":"Chamberlain","year":"2003","journal-title":"Neurosurgery."},{"key":"10.1016\/j.nrl.2019.10.010_bib0585","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-013-1175-6","article-title":"Breast cancer and leptomeningeal disease (LMD): Hormone receptor status influences time to development of LMD and survival from LMD","volume":"114","author":"Yust-Katz","year":"2013","journal-title":"J Neurooncol."},{"issue":"4 Suppl. 2","key":"10.1016\/j.nrl.2019.10.010_bib0590","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1053\/j.seminoncol.2009.05.006","article-title":"Treatment modalities for leptomeningeal metastases","volume":"36","author":"Shapiro","year":"2009","journal-title":"Semin Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0595","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1005803918194","article-title":"Carcinomatous meningitis secondary to breast cancer: Predictors of response to combined modality therapy","volume":"35","author":"Chamberlain","year":"1997","journal-title":"J Neurooncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0600","first-page":"505","article-title":"Leptomeningeal metastases due to melanoma","volume":"9","author":"Chamberlain","year":"1996","journal-title":"Int J Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0605","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/JTO.0b013e3182398e4f","article-title":"Leptomeningeal metastasis from non-small cell lung cancer: Survival and the impact of whole brain radiotherapy","volume":"7","author":"Morris","year":"2012","journal-title":"J Thorac Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0610","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-008-9758-3","article-title":"Pronostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors","volume":"93","author":"Waki","year":"2009","journal-title":"J Neurooncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0615","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/archneurol.2008.506","article-title":"Neoplastic meningitis related prognostic significance of the Karnosfky performance status","volume":"66","author":"Chamberlain","year":"2009","journal-title":"Arch Neurol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0620","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clbc.2016.07.002","article-title":"Characteristics and outcomes of patients with breast cancer with leptomeningeal metastasis","volume":"17","author":"Morikawa","year":"2017","journal-title":"Clin Breast Cancer."},{"key":"10.1016\/j.nrl.2019.10.010_bib0625","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1215\/15228517-2008-062","article-title":"Prognostic factors and outcomes in patients with leptomeningeal melanomatosis","volume":"10","author":"Harstad","year":"2008","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0630","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/JTO.0b013e3182773f21","article-title":"Leptomeningeal carcinomatosis in non-small-cell lung cancer patients impact on survival and correlated prognostic factors","volume":"8","author":"Lee","year":"2013","journal-title":"J Thorac Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0635","unstructured":"National Comprehensive Cancer Network (NCCN): Clinical Practice Guidelines in Oncology (NCCN Guidelines) \u2014 Cenral Nervous System Cancers. Version I. 2016."},{"key":"10.1016\/j.nrl.2019.10.010_bib0640","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00432-010-0831-x","article-title":"Prognostic factors and treatment options in patients with leptomeningeal metastases of diferent primary tumors: A retrospective analysis","volume":"136","author":"Oechsle","year":"2010","journal-title":"J Cancer Res Clin Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0645","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/cncr.24921","article-title":"Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis","volume":"116","author":"4Glantz","year":"2010","journal-title":"Cancer."},{"key":"10.1016\/j.nrl.2019.10.010_bib0650","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0002-9343(82)90404-1","article-title":"Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. An evaluation using 111indium-DTPA ventriculography","volume":"73","author":"Grossman","year":"1982","journal-title":"Am J Med."},{"key":"10.1016\/j.nrl.2019.10.010_bib0655","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1212\/WNL.46.6.1674","article-title":"Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastases","volume":"46","author":"Chamberlain","year":"1996","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2019.10.010_bib0660","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1212\/WNL.50.2.438","article-title":"111Indium-diethylenetriamine penta-acetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases","volume":"50","author":"Mason","year":"1998","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2019.10.010_bib0665","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1005982826121","article-title":"Radioisotope CSF flow studies in leptomeningeal metastases","volume":"38","author":"Chamberlain","year":"1998","journal-title":"J Neurooncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0670","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.1993.11.3.561","article-title":"Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis","volume":"11","author":"Grossman","year":"1993","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0675","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.1987.5.10.1655","article-title":"A prospective randomized trial single-agent versus combination chemotherapy in meningeal carcinomatosis","volume":"5","author":"Hitchins","year":"1987","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0680","first-page":"3394","article-title":"A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt\u00ae) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumours","volume":"5","author":"Glantz","year":"1999","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.nrl.2019.10.010_bib0685","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1200\/jco.2006.24.18_suppl.1528","article-title":"A randomized phaseIII\/IV study to determine benefit and safety of cytarabine liposome injection for the treatment of neoplastic meningitis","volume":"24","author":"Shapiro","year":"2006","journal-title":"Proc Am Soc Clin Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0690","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM197507242930402","article-title":"Methotrexate: Distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections","volume":"293","author":"Shapiro","year":"1975","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nrl.2019.10.010_bib0695","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","article-title":"Randomized trial of slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis","volume":"17","author":"Glantz","year":"1999","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0700","first-page":"3394","article-title":"A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors","volume":"5","author":"Glantz","year":"1999","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.nrl.2019.10.010_bib0705","first-page":"885","article-title":"Treatment of malignant meningeal disease with intrathecal thioTEPA: A phaseII study","volume":"61","author":"Gutin","year":"1977","journal-title":"Cancer Treat Rep."},{"key":"10.1016\/j.nrl.2019.10.010_bib0710","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/1097-0142(197610)38:4<1471::AID-CNCR2820380404>3.0.CO;2-0","article-title":"Intrathecal N, N\u2019 N\u203f-triethylenethiophosphoramide [thio-TEPA (NSC 6396)] in the treatment of malignant disease","volume":"38","author":"Gutin","year":"1976","journal-title":"Cancer."},{"key":"10.1016\/j.nrl.2019.10.010_bib0715","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.2146\/ajhp060165","article-title":"Intrathecal topotecan in adult patients with neoplastic meiningitis","volume":"63","author":"Gammon","year":"2006","journal-title":"Am J Health Syst Pharm."},{"key":"10.1016\/j.nrl.2019.10.010_bib0720","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1215\/15228517-2007-059","article-title":"A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies","volume":"10","author":"Glantz","year":"2008","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0725","first-page":"154674","article-title":"Intrathecal trastuzumab treatment of the neoplastic meningitis due to breast cancer: A case report and review of the literature","volume":"2013","author":"Dumitrescu","year":"2013","journal-title":"Case Rep Oncol Med."},{"key":"10.1016\/j.nrl.2019.10.010_bib0730","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-013-2525-y","article-title":"Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: A systematic review and pooled analysis","volume":"139","author":"Zagouri","year":"2013","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.nrl.2019.10.010_bib0735","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.breast.2015.11.005","article-title":"Sanctuary site leptomeningeal metastases in HER-2 positive breast cancer: A review in the era of trastuzumab","volume":"26","author":"Kordbacheh","year":"2016","journal-title":"Breast."},{"key":"10.1016\/j.nrl.2019.10.010_bib0740","doi-asserted-by":"crossref","first-page":"e000283","DOI":"10.1136\/esmoopen-2017-000283","article-title":"Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2","volume":"3","author":"Glitza","year":"2018","journal-title":"ESMO Open."},{"key":"10.1016\/j.nrl.2019.10.010_bib0745","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1227\/00006123-198801010-00016","article-title":"Antibiotic therapy for infected Ommaya reservoir systems","volume":"22","author":"Siegal","year":"1988","journal-title":"Neurosurgery."},{"key":"10.1016\/j.nrl.2019.10.010_bib0750","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jinf.2013.12.002","article-title":"Ommaya reservoir-related infections: clinical manifestations and treatment outcomes","volume":"68","author":"Szvalb","year":"2014","journal-title":"J Infect."},{"key":"10.1016\/j.nrl.2019.10.010_bib0755","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/B978-0-7020-4088-7.00080-8","article-title":"Neurologic complications of chemotherapy and other newer and experimental approaches","volume":"121","author":"Soffietti","year":"2014","journal-title":"Handb Clin Neurol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0760","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000069773","article-title":"Biochemical and clinical aspects of methotrexate neurotoxicity","volume":"49","author":"Vezmar","year":"2003","journal-title":"Chemotherapy."},{"key":"10.1016\/j.nrl.2019.10.010_bib0765","series-title":"Neurologic Complications of Cancer. Contemporary Neurology Series","first-page":"447","article-title":"Side effects of chemotherapy","author":"De Angelis","year":"2009"},{"key":"10.1016\/j.nrl.2019.10.010_bib0770","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11060-015-1727-z","article-title":"Myelopathy following intrathecal chemotherapy in adults: a single institution experience","volume":"122","author":"Cachia","year":"2015","journal-title":"J Neurooncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0775","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1080\/10428190802220527","article-title":"Intrathecal liposomal cytarabine: More friend than foe?","volume":"49","author":"Bhohojwani","year":"2008","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.nrl.2019.10.010_bib0780","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/JTO.0b013e3182398e4f","article-title":"Leptomeningeal metastasis from non-small cell lung cancer: Survival and the impact of whole brain radiotherapy","volume":"7","author":"Morris","year":"2012","journal-title":"J Thorac Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0785","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00066-011-0025-8","article-title":"Outcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumors","volume":"188","author":"Gani","year":"2012","journal-title":"Strahlenther Onkol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0790","doi-asserted-by":"crossref","first-page":"644","DOI":"10.6004\/jnccn.2005.0038","article-title":"Central nervous system cancers: Clinical practice guidelines in oncology","volume":"3","author":"Brem","year":"2005","journal-title":"J Natl Compr Canc Netw."},{"key":"10.1016\/j.nrl.2019.10.010_bib0800","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jns.2004.05.008","article-title":"Leptomeningeal metastasis: Survival and prognostic factors in 155 patients","volume":"223","author":"Herrlinger","year":"2004","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.nrl.2019.10.010_bib0805","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.1998.16.4.1561","article-title":"High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: Is intrathecal chemotherapy necessary?","volume":"16","author":"Glantz","year":"1998","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0810","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11060-012-0879-3","article-title":"PhaseII trial of temozolomide for leptomeningeal metastases in patients with solid tumors","volume":"109","author":"Segura","year":"2012","journal-title":"J Neurooncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0815","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1215\/S1152851703000334","article-title":"Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy","volume":"6","author":"Rogers","year":"2004","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0820","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/ijms17071074","article-title":"Molecular targeted therapies for the treatment of leptomeningeal carcinomatosis: Current evidence and future directions","volume":"17","author":"Lee","year":"2016","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.nrl.2019.10.010_bib0855","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/JTO.0000000000000669","article-title":"Epidermal growth factor receptor tyrosine kinase inhibitors for non-small-cell lung cancer patients with leptomeningeal carcinomatosis","volume":"10","author":"Liao","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0830","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.18632\/oncotarget.2886","article-title":"A phaseI trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer","volume":"6","author":"Jackman","year":"2015","journal-title":"Oncotarget."},{"key":"10.1016\/j.nrl.2019.10.010_bib0835","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/ijc.30147","article-title":"Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy","volume":"139","author":"Smalley","year":"2016","journal-title":"Int J Cancer."},{"key":"10.1016\/j.nrl.2019.10.010_bib0840","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/s12885-015-1391-x","article-title":"Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: A case report","volume":"15","author":"Kim","year":"2015","journal-title":"BMC Cancer."},{"key":"10.1016\/j.nrl.2019.10.010_bib0845","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1007\/s00415-012-6488-4","article-title":"Clinical and radiological response of leptomeningeal melanoma after whole brain radiotherapy and ipilimumab","volume":"259","author":"Bot","year":"2012","journal-title":"J Neurol."},{"key":"10.1016\/j.nrl.2019.10.010_bib0850","first-page":"484","article-title":"Leptomeningeal metastases: A RANO proposal for response criteria","volume":"19","author":"Chamberlain","year":"2017","journal-title":"Neuro Oncol."}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485319301410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485319301410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:14:04Z","timestamp":1759324444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485319301410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":84,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0213485319301410"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2019.10.010","relation":{},"ISSN":["0213-4853"],"issn-type":[{"type":"print","value":"0213-4853"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meningitis neopl\u00e1sica en tumores s\u00f3lidos: revisi\u00f3n actualizada de diagn\u00f3stico, pron\u00f3stico, manejo terap\u00e9utico y direcciones futuras","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2019.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}